Show simple item record

Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation

dc.contributor.authorThompson-Coon, Jo
dc.contributor.authorHoyle, M
dc.contributor.authorGreen, C
dc.contributor.authorLiu, Z
dc.contributor.authorWelch, K
dc.contributor.authorMoxham, T
dc.contributor.authorStein, Ken
dc.date.accessioned2013-07-04T10:41:46Z
dc.date.issued2010-01
dc.description.abstractTo assess the clinical effectiveness and cost-effectiveness of bevacizumab, combined with interferon (IFN), sorafenib tosylate, sunitinib and temsirolimus in the treatment of people with advanced and/or metastatic renal cell carcinoma (RCC).en_GB
dc.identifier.citationHealth Technology Assessment, 2010, Vol. 14, Issue 2, pp. 1 - iven_GB
dc.identifier.doi10.3310/hta14020
dc.identifier.urihttp://hdl.handle.net/10871/11528
dc.language.isoenen_GB
dc.publisherNIHR Health Technology Assessment Programmeen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/20028613en_GB
dc.relation.urlhttp://www.journalslibrary.nihr.ac.uk/hta/volume-14/issue-2en_GB
dc.subjectAntibodies, Monoclonalen_GB
dc.subjectAntibodies, Monoclonal, Humanizeden_GB
dc.subjectAntineoplastic Combined Chemotherapy Protocolsen_GB
dc.subjectBenzenesulfonatesen_GB
dc.subjectCarcinoma, Renal Cellen_GB
dc.subjectCost-Benefit Analysisen_GB
dc.subjectHumansen_GB
dc.subjectIndolesen_GB
dc.subjectKidney Neoplasmsen_GB
dc.subjectPyridinesen_GB
dc.subjectPyrrolesen_GB
dc.subjectSirolimusen_GB
dc.titleBevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluationen_GB
dc.typeArticleen_GB
dc.date.available2013-07-04T10:41:46Z
exeter.place-of-publicationEngland
dc.descriptionaddresses: Peninsula Technology Assessment Group, Peninsula College of Medicine and Dentistry, University of Exeter, UK.en_GB
dc.descriptiontypes: Journal Article; Reviewen_GB
dc.descriptionPublished version. Copyright © 2010 NIHR Health Technology Assessment Programmeen_GB
dc.identifier.journalHealth Technology Assessmenten_GB


Files in this item

Name:
2010 Hlth Tech Ass Bevacizumab... ...
Size:
2.259Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record